| J9271 | Injection, pembrolizumab, 1 mg | 23,600 | $40 | $1M |
| J9299 | Injection, nivolumab, 1 mg | 19,640 | $20 | $471.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,150 | $100 | $115.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,000 | $70 | $71.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 520 | $110 | $56K |
| J0897 | Injection, denosumab, 1 mg | 3,240 | $20 | $55.1K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 310 | $100 | $30.7K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 120 | $130 | $16.4K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 480 | $20 | $11.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 80 | $130 | $10.6K |